Alasmary Mohammed Yahia
Medical Department, College of Medicine, Najran University, Najran 1988, Saudi Arabia.
Clin Pract. 2021 Sep 14;11(3):650-658. doi: 10.3390/clinpract11030080.
To explore the prevalence of urinary tract infections (UTIs) among female patients in the Najran region of Saudi Arabia and determine their antimicrobial resistance pattern.
This study was conducted on 136 urine samples collected from outpatient departments (OPDs) of the different government hospitals in the Najran region of Saudi Arabia. Over one year, the results of susceptibility testing reports of outpatient midstream urine samples from three government hospitals were prospectively evaluated.
Of 136 urine samples, only 123 (90.45%) were found to show significant growth for UTIs, from which 23 different uropathogens were identified. (58.5%) was the most commonly isolated organism, followed by (8.1%). The isolated microorganism showed increased resistance patterns from 3.3% to 62.6%, with an overall resistance of 27.19%. Meropenem was the most effective antimicrobial, followed by amikacin and ertapenem (0.47%, 0.91%, and 1.5% resistance, respectively). At the same time, ampicillin and cephazolin were the least (62.6% and 59.5% resistance, respectively) effective. Overall, eleven (8.94%) uropathogens isolates were ESBLs, among which there were eight (6.5%) , one (0.81%) , one (0.81%) , and one (0.81%) .
remains the most commonly isolated causative uropathogens, followed by species. The prevalence of pathogenic and species underscores the importance of developing cost-effective, precise, and rapid identification systems to minimize public exposure to uropathogens. Antibiotic susceptibility data revealed that most of the isolates were resistant to the majority of the antibiotics. The patients with UTIs in the Najran region of Saudi Arabia are at a high risk of antibiotic resistance, leading to significant problems in outpatient department (OPD) treatment outcomes and raising the alarm for the physician to change their empiric treatment.
探讨沙特阿拉伯纳季兰地区女性患者尿路感染(UTIs)的患病率,并确定其抗菌药物耐药模式。
本研究对从沙特阿拉伯纳季兰地区不同政府医院门诊部(OPD)收集的136份尿液样本进行。在一年多的时间里,对三家政府医院门诊中段尿液样本的药敏试验报告结果进行了前瞻性评估。
在136份尿液样本中,仅123份(90.45%)被发现有UTIs显著生长,从中鉴定出23种不同的尿路病原体。(58.5%)是最常分离出的病原体,其次是(8.1%)。分离出的微生物耐药模式从3.3%增加到62.6%,总体耐药率为27.19%。美罗培南是最有效的抗菌药物,其次是阿米卡星和厄他培南(耐药率分别为0.47%、0.91%和1.5%)。同时,氨苄西林和头孢唑林效果最差(耐药率分别为62.6%和59.5%)。总体而言,11株(8.94%)尿路病原体分离株为超广谱β-内酰胺酶(ESBLs),其中有8株(6.5%),1株(0.81%),1株(0.81%),1株(0.81%)。
仍然是最常分离出的致病性尿路病原体,其次是物种。致病性和物种的流行凸显了开发具有成本效益、精确和快速的鉴定系统以尽量减少公众接触尿路病原体的重要性。抗生素敏感性数据显示,大多数分离株对大多数抗生素耐药。沙特阿拉伯纳季兰地区的UTIs患者面临着较高的抗生素耐药风险,导致门诊部(OPD)治疗结果出现重大问题,并向医生敲响了改变经验性治疗的警钟。